昭衍新药(06127.HK)拟10月30日举行董事会会议审批季度业绩

Core Viewpoint - Zhaoyan New Drug (06127.HK) has announced a board meeting scheduled for October 30, 2025, to consider and approve the third quarter performance for the nine months ending September 30, 2025, along with its release [1] Summary by Category - Company Announcement - The company will hold a board meeting on October 30, 2025, to discuss the third quarter results [1] - The performance report will cover the period ending September 30, 2025 [1]